Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

17.83USD
22 May 2015
Change (% chg)

$-0.04 (-0.22%)
Prev Close
$17.87
Open
$17.83
Day's High
$17.94
Day's Low
$17.77
Volume
983,638
Avg. Vol
2,430,523
52-wk High
$18.49
52-wk Low
$11.11

BSX.N

Chart for BSX.N

About

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company operates in three segments, including Cardiovascular, Rhythm Management and MedSurg. The Company’s cardiovascular segment includes Interventional Cardiology and... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $23,957.88
Shares Outstanding(Mil.): 1,340.68
Dividend: --
Yield (%): --

Financials

Search Stocks

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters May 5, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events. ** For

05 May 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters May 1, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events.

01 May 2015

DIARY-U.S. MEETINGS/WEEK AHEAD

Thomson Reuters April 30, 2015 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - MONTH AHEAD Dividends Non S&P 500 - Weekly Federal Reserve events ConferenceCall/Webcast - Weekly Meetings - Weekly Xtra users can see more details on conference calls & webcasts by hovering your mouse over the RIC, right click, no click on Related Co Data, now click on Co Events.

30 Apr 2015

Boston Scientific says atrial fibrillation device in demand

- Boston Scientific Corp expects more hospitals will be able to offer its new atrial fibrillation treatment starting by the end of the third quarter as it paces the product's rollout to give physicians time to learn how to use it, its chief executive said.

29 Apr 2015

UPDATE 1-Boston Scientific reaches first transvaginal mesh settlement

April 28 - Boston Scientific Corp on Tuesday said it reached its first settlement agreement to resolve a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.

28 Apr 2015

Boston Scientific says to settle some transvaginal mesh cases

April 28 - Boston Scientific Corp on Tuesday said it has reached an agreement to settle a portion of the legal claims it faces involving its transvaginal mesh product to treat urinary incontinence.

28 Apr 2015

Boston Scientific says reaches conditional settlement in some transvaginal mesh cases

April 28 - Boston scientific says it reached conditional agreement to settle some transvaginal mesh cases Boston scientific says it will pay about $119 million to resolve 2,970 cases Boston scientific says it increased its product liability reserves for transvaginal mesh litigation Boston scientific says reserves cover known and estimated future cases (Reporting by Susan Kelly in Chicago)

28 Apr 2015

UPDATE 1-Boston Scientific cuts full-year forecast as legal costs weigh

April 28 - Medical device maker Boston Scientific Corp cut its full-year revenue and profit forecasts as it continues to bear the brunt of charges from a number of lawsuits.

28 Apr 2015

Boston Scientific posts loss on litigation costs

April 28 - Medical device maker Boston Scientific Corp reported a quarterly net loss due to one-time charges, including litigation costs of $193 million.

28 Apr 2015

RPT-Wall St Week Ahead-Investors seek protection against healthcare stock decline

NEW YORK, April 24 - Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

26 Apr 2015

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $49.03 -0.31
St. Jude Medical, Inc. (STJ.N) $74.27 -0.47

Earnings vs. Estimates

Search Stocks